2026-09-15 13:12 UTC
Purdue Pharma + Opioid Crisis (1996 to now)
Purdue launched OxyContin in 1996 via marketing that claimed a lower addiction risk than other opioids. Internal company documents later came out in court showing executives knew the drug carried serious abuse & addiction risks, and suppressed research while pushing aggressive sales tactics on doctors,
Replies (1)
-
@joecardillo@federate.social 2026-09-15 13:12
Once the epidemic became impossible to deny, Purdue and other opioid makers advanced "abuse-deterrent formulations" as a solution to the crisis they created, and Purdue even got a patent extension that allowed them to block cheaper generic drugs from entering the market.